Growing community of inventors

Penzberg, Germany

Michael Cannarile

Average Co-Inventor Count = 4.80

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Michael CannarileCarola Ries (1 patent)Michael CannarileDominik Ruettinger (1 patent)Michael CannarileMartin Weisser (1 patent)Michael CannarileRaymond Barlow (1 patent)Michael CannarileFrancesca Michielin (1 patent)Michael CannarileAxel Mescheder (1 patent)Michael CannarileAnna-Maria Jegg (1 patent)Michael CannarileGeorgina Meneses-Lorente (1 patent)Michael CannarileKatharina Wartha (0 patent)Michael CannarileMichael Cannarile (2 patents)Carola RiesCarola Ries (21 patents)Dominik RuettingerDominik Ruettinger (3 patents)Martin WeisserMartin Weisser (3 patents)Raymond BarlowRaymond Barlow (1 patent)Francesca MichielinFrancesca Michielin (1 patent)Axel MeschederAxel Mescheder (1 patent)Anna-Maria JeggAnna-Maria Jegg (1 patent)Georgina Meneses-LorenteGeorgina Meneses-Lorente (1 patent)Katharina WarthaKatharina Wartha (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Hoffmann-la Roche Inc. (1 from 4,945 patents)

2. Synox Therapeutics UK Limited (1 from 1 patent)

3. F. Hoffmann-la Roche Ag (168 patents)


2 patents:

1. 12454573 - Dosages of emactuzumab

2. 11498968 - Treatment of tumors with an anti-CSF-1R antibody in combination with an anti-PD-L1 antibody after failure of anti-PD-L1/PD1 treatment

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/25/2025
Loading…